InterVenn Expands Global Presence to Drive the Potential of Glycoproteomics to Improve Patient Outcomes

SAN FRANCISCO--(BUSINESS WIRE)--InterVenn Biosciences, a clinical technology company leveraging glycoproteomics to transform the future of healthcare, today announced that it has expanded its global presence with the opening of multiple new locations in Asia-Pacific and North America. The company’s new facilities include Mandaluyong, Philippines; Kuala Lumpur, Malaysia; Melbourne, Australia; and San Diego, California, adding a large footprint of state-of-the-art laboratories and office space fo